Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to LMWX-80 Enoxaparin Sodium Injection 80mg:
LMWX-80 Enoxaparin Sodium Injection 80mg is a clinically proven low molecular weight heparin, essential for preventing and treating venous thromboembolism (VTE). This injectable solution is a vital component in the management of patients at risk of developing blood clots.
Uses of LMWX-80 Enoxaparin Sodium Injection 80mg:
LMWX-80 is indicated for:
Prevention of deep vein thrombosis (DVT) in patients undergoing surgery
Treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE)
Prevention of thromboembolic complications in high-risk patients
Benefits of LMWX-80 Enoxaparin Sodium Injection 80mg:
Effective anticoagulation for the prevention of blood clots
Easy-to-administer injectable formulation for convenience
Reduced risk of thromboembolic events in at-risk populations
Proven safety and efficacy profile in clinical practice
Mechanism of Action of LMWX-80 Enoxaparin Sodium Injection 80mg:
Enoxaparin, the active ingredient in LMWX-80, works by inhibiting factor Xa and factor IIa (thrombin) in the coagulation cascade. This action decreases the formation of fibrin clots, leading to effective anticoagulation and reduced risk of thromboembolic events, making LMWX-80 an essential tool in thromboprophylaxis and treatment.